Mrs. Adele Lavigne, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25 S Grafton St, Romney, WV 26757 Phone: 304-851-5432 |
News Archive
For patients with moderate pain after foot surgery, the cyclo-oxygenase 2 (COX-2) inhibitor drug etoricoxib provides better pain relief with fewer side effects than the opioid drug tramadol, concludes a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Patients with cochlear implants may want to steer clear of certain magnetic imaging devices, such as 3T MRI machines, because the machines can demagnetize the patient's implant, according to new research published in the December 2008 issue of Otolaryngology - Head and Neck Surgery.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.
Boston Scientific Corporation has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
The review, published in the British Ecological Society Journal People and Nature, is the first to focus on nature connection in children and adolescents.
› Verified 6 days ago